- Home
- INGM vs BHVN Comparison
INGM vs BHVN Comparison
Compare INGM & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGM
- BHVN
- Stock Information
- Founded
- INGM 1979
- BHVN 2013
- Country
- INGM United States
- BHVN United States
- Employees
- INGM N/A
- BHVN N/A
- Industry
- INGM
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- INGM
- BHVN Health Care
- Exchange
- INGM NYSE
- BHVN Nasdaq
- Market Cap
- INGM 5.7B
- BHVN 4.7B
- IPO Year
- INGM 2024
- BHVN 2017
- Fundamental
- Price
- INGM $20.94
- BHVN $39.16
- Analyst Decision
- INGM Buy
- BHVN Strong Buy
- Analyst Count
- INGM 13
- BHVN 13
- Target Price
- INGM $27.58
- BHVN $63.00
- AVG Volume (30 Days)
- INGM 300.3K
- BHVN 887.1K
- Earning Date
- INGM 11-12-2024
- BHVN 11-12-2024
- Dividend Yield
- INGM N/A
- BHVN N/A
- EPS Growth
- INGM 0.17
- BHVN N/A
- EPS
- INGM 1.43
- BHVN N/A
- Revenue
- INGM $47,658,502,000.00
- BHVN N/A
- Revenue This Year
- INGM N/A
- BHVN N/A
- Revenue Next Year
- INGM N/A
- BHVN $197.09
- P/E Ratio
- INGM $14.65
- BHVN N/A
- Revenue Growth
- INGM N/A
- BHVN N/A
- 52 Week Low
- INGM $20.61
- BHVN $26.80
- 52 Week High
- INGM $25.69
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- INGM N/A
- BHVN 36.25
- Support Level
- INGM N/A
- BHVN $36.70
- Resistance Level
- INGM N/A
- BHVN $42.13
- Average True Range (ATR)
- INGM 0.00
- BHVN 2.59
- MACD
- INGM 0.00
- BHVN -0.43
- Stochastic Oscillator
- INGM 0.00
- BHVN 22.26
About INGM INGRAM MICRO HOLDING CORPORATION
Ingram Micro Holding Corp is a technology company for the global information technology ecosystem. It plays a vital role in the IT sales channel, bringing products and services from technology manufacturers and cloud providers to business-to-business technology experts. The company also provide a broad range of technology services, including financing, specialized marketing, and lifecycle management, as well as technical pre- and post-sales professional support.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.